Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis.

Trial Profile

Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 May 2013

At a glance

  • Drugs Fludarabine (Primary) ; Rituximab (Primary)
  • Indications Chronic lymphocytic leukaemia; Lymphoma
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 16 Nov 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
    • 16 Nov 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
    • 16 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top